Aktie 002750 KUNMING LONGJIN PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kunming Longjin Pharmaceutical Co., Ltd.

Aktien

002750

CNE1000021X8

002750

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 29.04.2024 		% 5 Tage % 1. Jan.
5,87 CNY +2,09 % Intraday Chart für Kunming Longjin Pharmaceutical Co., Ltd. +2,09 % -41,30 %
29.04. Kunming Longjin Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
29.04. Kunming Longjin Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Kunming Longjin Pharmaceutical Co., Ltd. Approves Board Elections
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Kunming Longjin Pharmaceutical's Shareholder Plans to Cut 6% Stake
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Longjin Approves Election of Directors
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
Yunnan Longjin Fantian Biological Technology Co., Ltd. announced that it has received CNY 48 million in funding from Kunming Longjin Pharmaceutical Co., Ltd.
Yunnan Longjin Fantian Biological Technology Co., Ltd. announced that it expects to receive CNY 48 million in funding from Kunming Longjin Pharmaceutical Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002750 Aktie
  4. Nachrichten Kunming Longjin Pharmaceutical Co., Ltd.
  5. Andere Sprachen